+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pediatric Neuroblastoma Treatment"

Pediatric Neuroblastoma Treatment Global Market Report 2024 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Pediatric Neuroblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Pediatric Neuroblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Pediatric Neuroblastoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pediatric Neuroblastoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Pediatric Neuroblastoma Treatment is a type of oncology drug used to treat a type of cancer that affects children. It is a type of cancer that develops from immature nerve cells found in various parts of the body. Neuroblastoma is the most common cancer in infants and the most common solid tumor in children. Treatment for pediatric neuroblastoma typically involves a combination of surgery, chemotherapy, radiation therapy, and immunotherapy. Surgery is used to remove the tumor, while chemotherapy and radiation therapy are used to kill any remaining cancer cells. Immunotherapy is used to help the body's immune system fight the cancer. Some companies in the Pediatric Neuroblastoma Treatment market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more